| P2093 | author name string | Kyung Jin Lee | |
| | Geun Hyang Kim | |
| | Gyun-Sik Oh | |
| | Jin Yoon | |
| | Seung-Whan Kim | |
| | Hae Won Kim | |
| P2860 | cites work | Activation of Wnt/beta-catenin signaling increases insulin sensitivity through a reciprocal regulation of Wnt10b and SREBP-1c in skeletal muscle cells | Q21142682 |
| | Molecular cloning, chromosomal localization, tissue mRNA levels, bacterial expression, and enzymatic properties of human NMN adenylyltransferase | Q24290390 |
| | Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse | Q24564225 |
| | Signal transducer and activator of transcription (STAT)-induced STAT inhibitor 1 (SSI-1)/suppressor of cytokine signaling 1 (SOCS1) inhibits insulin signal transduction pathway through modulating insulin receptor substrate 1 (IRS-1) phosphorylation | Q24675835 |
| | A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 |
| | Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 |
| | Suppressors of cytokine signaling-1 and -6 associate with and inhibit the insulin receptor. A potential mechanism for cytokine-mediated insulin resistance | Q28187852 |
| | SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2 | Q28201656 |
| | SREBP-1c transcription factor and lipid homeostasis: clinical perspective | Q28291930 |
| | Deletion of the cancer-amplified coactivator AIB3 results in defective placentation and embryonic lethality | Q28507924 |
| | Regulation of insulin secretion and beta-cell mass by activating signal cointegrator 2 | Q28566652 |
| | Ageing increases SOCS-3 expression in rat hypothalamus: effects of food restriction | Q28570150 |
| | The metabolic syndrome | Q33569142 |
| | Deconstructing type 2 diabetes | Q33591808 |
| | Targeted disruption of the CREB coactivator Crtc2 increases insulin sensitivity | Q33733839 |
| | PPAR gamma and the treatment of insulin resistance | Q34066578 |
| | Diabetes and obesity: the twin epidemics | Q34482313 |
| | Attenuation of leptin and insulin signaling by SOCS proteins | Q36607776 |
| | Protein-tyrosine phosphatase 1B expression is induced by inflammation in vivo | Q36662772 |
| | SREBP-1c and TFE3, energy transcription factors that regulate hepatic insulin signaling | Q36728656 |
| | ChREBP, a transcriptional regulator of glucose and lipid metabolism | Q36788526 |
| | Molecular basis of oncostatin M-induced SOCS-3 expression in astrocytes | Q37052050 |
| | Novel approach to treat insulin resistance, type 2 diabetes, and the metabolic syndrome: simultaneous activation of PPARalpha, PPARgamma, and PPARdelta | Q37065580 |
| | A critical role of Sp1 transcription factor in regulating gene expression in response to insulin and other hormones | Q37229501 |
| | Sensitivity of lipid metabolism and insulin signaling to genetic alterations in hepatic peroxisome proliferator-activated receptor-gamma coactivator-1alpha expression | Q37236343 |
| | FoxO1 links insulin resistance to proinflammatory cytokine IL-1beta production in macrophages. | Q37400789 |
| | Metformin and insulin suppress hepatic gluconeogenesis through phosphorylation of CREB binding protein | Q37417220 |
| | Dissecting the role of insulin resistance in the metabolic syndrome | Q37472798 |
| | Cellular mechanisms of insulin resistance: role of stress-regulated serine kinases and insulin receptor substrates (IRS) serine phosphorylation | Q37580452 |
| | Foxo1 integrates insulin signaling with mitochondrial function in the liver | Q37715192 |
| | Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease | Q37742798 |
| | Dual DNA binding specificity of ADD1/SREBP1 controlled by a single amino acid in the basic helix-loop-helix domain | Q38295909 |
| | Increased expression of the sterol regulatory element-binding protein-1 gene in insulin receptor substrate-2(-/-) mouse liver | Q38297185 |
| | Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice. | Q38311106 |
| | Differential effects of pharmacological liver X receptor activation on hepatic and peripheral insulin sensitivity in lean and ob/ob mice | Q38325289 |
| | Prevention of hepatic steatosis and hepatic insulin resistance by knockdown of cAMP response element-binding protein | Q38348521 |
| | Molecular mechanism of lipopolysaccharide-induced SOCS-3 gene expression in macrophages and microglia. | Q40065423 |
| | Analysis of chromatin structure by in vivo formaldehyde cross-linking. | Q41132202 |
| | Liver X receptor agonists ameliorate TNFalpha-induced insulin resistance in murine brown adipocytes by downregulating protein tyrosine phosphatase-1B gene expression | Q42503440 |
| | SOCS-3 is an insulin-induced negative regulator of insulin signaling | Q42801701 |
| | Adipocyte CREB promotes insulin resistance in obesity | Q43065389 |
| | PGC-1 promotes insulin resistance in liver through PPAR-alpha-dependent induction of TRB-3. | Q44859720 |
| | SREBPs suppress IRS-2-mediated insulin signalling in the liver | Q47868873 |
| | Inhibition of transcription of the phosphoenolpyruvate carboxykinase gene by insulin | Q59089319 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 437-447 | |
| P577 | publication date | 2012-11-01 | |
| P1433 | published in | Biochemical Journal | Q864221 |
| P1476 | title | Regulation of hepatic insulin sensitivity by activating signal co-integrator-2. | |
| P478 | volume | 447 | |